hugoGeneSymbol	genomicLocationDescription	defaultEffect	comment	context	variant	genomicLocation	transcriptId	hgvsc	vepPredictedProteinEffect	vepPredictedVariantClassification	revisedProteinEffect	revisedVariantClassification	revisedStandardVariantClassification	otherVariation	confirmed	mutationOrigin	variantNote	pubmedId	referenceText
KIT	Deletions flanking intron 10 - exon 11 boundary (e.g. 4:55593576_55593606del)	splice	Changes splice donor site, cause inframe deletion in exon 11	Actionable in GIST	4:g.55593576_55593606del	4,55593576,55593606,CCACAGAAACCCATGTATGAAGTACAGTGGA,-	ENST00000288135	ENST00000288135.5:c.1648-6_1672del	p.X550_splice	Splice_Site	p.K550_K558del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			15507676	Corless et al., 2004
KIT	Deletions flanking intron 10 - exon 11 boundary (e.g. 4:55593576_55593606del)	splice	Changes splice donor site, cause inframe deletion in exon 11	Actionable in GIST	4:g.55593580_55593606del	4,55593580,55593606,AGAAACCCATGTATGAAGTACAGTGGA,-	ENST00000288135	ENST00000288135.5:c.1648_1674del	p.X550_splice	Splice_Site	p.K550_K558del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			15507676	Corless et al., 2004
KIT	Deletions flanking intron 10 - exon 11 boundary (e.g. 4:55593576_55593606del)	splice	Changes splice donor site, cause inframe deletion in exon 11	Actionable in GIST	4:g.55593578_55593606del	4,55593578,55593606,ACAGAAACCCATGTATGAAGTACAGTGGA,-	ENST00000288135	ENST00000288135.5:c.1648-3_1673del	p.X550_splice	Splice_Site	p.K550_K558del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			15507676	Corless et al., 2004
APC	5:g.112151184A>G	splice	Introduces splice acceptor site causing a frameshift	Recurrent alteration in CRC	5:g.112151184A>G	5,112151184,112151184,A,G	ENST00000257430	ENST00000257430.4:c.835-8A>G	p.*279*	Splice_Region	p.G279Ffs*10	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins		TRUE			29316426	Yaeger et al., 2018
BAP1	3:g.52439306A>C	synonymous	Leads to exon 11 skipping	Recurrent and prognostic in kidney cancer	3:g.52439306A>C	3,52439306,52439306,A,C	ENST00000460680	ENST00000460680.1:c.936T>G	p.G312=	Silent	p.D311Gfs*23	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE			33681728	Niersch et al., 2021
KRAS	12:g.25380277G>T	missense	Introduces a splice donor site if Q61K is not co-occurring with G60G	Recurrent in many cancer types	12:g.25380277G>T	12,25380277,25380277,G,T	ENST00000256078	ENST00000256078.4:c.181C>A	p.Q61K	Missense_Mutation	p.X61	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE			35236983	Kobayashi et al., 2022
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266086_41266304del	3,41266086,41266304,AGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGCAGTTTTGAGAACTAAAA,-	ENST00000349496	ENST00000349496.5:c.86_241+63del	p.X29_splice	Splice_Site	p.Q28_D81del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266012_41266312del	3,41266012,41266312,TATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGCAGTTTTGAGAACTAAAAAGTTAGTG,-	ENST00000349496	ENST00000349496.5:c.14-1_241+72del	p.X5_splice	Splice_Site	p.A5_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266038_41266264del	3,41266038,41266264,TGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCAT,-	ENST00000349496	ENST00000349496.5:c.37_241+22del	p.X13_splice	Splice_Site	p.M12_D81del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265709_41266219del	3,41265709,41266219,TCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAG,-	ENST00000349496	ENST00000349496.5:c.13+141_220del	p.X5_splice	Splice_Site	p.A5_Q72del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266090_41266253del	3,41266090,41266253,TTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTA,-	ENST00000349496	ENST00000349496.5:c.90_241+12del	p.X30_splice	Splice_Site	p.S29_D81del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265579_41266277del	3,41265579,41266277,GTCATTAAATCTTTAGTTACTGAATTGGGGCTCTGCTTCGTTGCCATTAAGCCAGTCTGGCTGAGATCCCCCTGCTTTCCTCTCTCCCTGCTTACTTGTCAGGCTACCTTTTGCTCCATTTTCTGCTCACTCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAA,-	ENST00000349496	ENST00000349496.5:c.13+11_241+37del	p.X5_splice	Splice_Site	p.A5_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265722_41266253del	3,41265722,41266253,TTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTA,-	ENST00000349496	ENST00000349496.5:c.13+152_241+11del	p.X5_splice	Splice_Site	p.A5_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266029_41266287del	3,41266029,41266287,AGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGC,-	ENST00000349496	ENST00000349496.5:c.30_241+47del	p.X10_splice	Splice_Site	p.E9_D81del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266028_41266420del	3,41266028,41266420,GAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGCAGTTTTGAGAACTAAAAAGTTAGTGTATAATAGTTTAAATAAAATGTTGTGGTGAAGAAAAGAGAGTAATAGCAATGTCACTTTTACCATTTAGGATAGCAAATACTTAGGTAAATGCTGAACTGTGGATAGT,-	ENST00000349496	ENST00000349496.5:c.29_242-21del	p.X10_splice	Splice_Site	p.E9_D81del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266016_41266403del	3,41266016,41266403,GCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGCAGTTTTGAGAACTAAAAAGTTAGTGTATAATAGTTTAAATAAAATGTTGTGGTGAAGAAAAGAGAGTAATAGCAATGTCACTTTTACCATTTAGGATAGCAAATACTTAGGTAAAT,-	ENST00000349496	ENST00000349496.5:c.18_242-37del	p.X6_splice	Splice_Site	p.A5_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265975_41266211del	3,41265975,41266211,CATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGAT,-	ENST00000349496	ENST00000349496.5:c.14-42_208del	p.X5_splice	Splice_Site	p.A5_G69del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265908_41266236del	3,41265908,41266236,TTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACA,-	ENST00000349496	ENST00000349496.5:c.14-109_233del	p.X5_splice	Splice_Site	p.A5_Q79del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266013_41266355del	3,41266013,41266355,ATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGCAGTTTTGAGAACTAAAAAGTTAGTGTATAATAGTTTAAATAAAATGTTGTGGTGAAGAAAAGAGAGTA,-	ENST00000349496	ENST00000349496.5:c.15_242-85del	p.X5_splice	Splice_Site	p.A5_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265897_41266218del	3,41265897,41266218,GTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCA,-	ENST00000349496	ENST00000349496.5:c.14-117_218del	p.X5_splice	Splice_Site	p.A5_Q72del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41266002_41266029del	3,41266002,41266029,GTTTCGTATTTATAGCTGATTTGATGGA,-	ENST00000349496	ENST00000349496.5:c.14-12_29del	p.X5_splice	Splice_Site	p.A5_E9del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265562_41266260del	3,41265562,41266260,GGCTACTCAAGGTTTGTGTCATTAAATCTTTAGTTACTGAATTGGGGCTCTGCTTCGTTGCCATTAAGCCAGTCTGGCTGAGATCCCCCTGCTTTCCTCTCTCCCTGCTTACTTGTCAGGCTACCTTTTGCTCCATTTTCTGCTCACTCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTT,-	ENST00000349496	ENST00000349496.5:c.3_241+16del	p.X1_splice	Splice_Site	p.A2_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265568_41266266del	3,41265568,41266266,TCAAGGTTTGTGTCATTAAATCTTTAGTTACTGAATTGGGGCTCTGCTTCGTTGCCATTAAGCCAGTCTGGCTGAGATCCCCCTGCTTTCCTCTCTCCCTGCTTACTTGTCAGGCTACCTTTTGCTCCATTTTCTGCTCACTCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTG,-	ENST00000349496	ENST00000349496.5:c.9_241+22del	p.X3_splice	Splice_Site	p.Q4_D81del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265571_41266206del	3,41265571,41266206,AGGTTTGTGTCATTAAATCTTTAGTTACTGAATTGGGGCTCTGCTTCGTTGCCATTAAGCCAGTCTGGCTGAGATCCCCCTGCTTTCCTCTCTCCCTGCTTACTTGTCAGGCTACCTTTTGCTCCATTTTCTGCTCACTCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACA,-	ENST00000349496	ENST00000349496.5:c.12_203del	p.X4_splice	Splice_Site	p.A5_Q68del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265648_41266493del	3,41265648,41266493,CCCTGCTTTCCTCTCTCCCTGCTTACTTGTCAGGCTACCTTTTGCTCCATTTTCTGCTCACTCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATTTTCTCAGTCCTTCACTCAAGAACAAGTAGCTGGTAAGAGTATTATTTTTCATTGCCTTACTGAAAGTCAGAATGCAGTTTTGAGAACTAAAAAGTTAGTGTATAATAGTTTAAATAAAATGTTGTGGTGAAGAAAAGAGAGTAATAGCAATGTCACTTTTACCATTTAGGATAGCAAATACTTAGGTAAATGCTGAACTGTGGATAGTGAGTGTTGAATTAACCTTTTCCAGATATTGATGGACAGTATGCAATGACTCGAGCTCAGAGGGTACGAGCTGC,-	ENST00000349496	ENST00000349496.5:c.13+76_290del	p.X5_splice	Splice_Site	p.A5_A97del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265674_41266212del	3,41265674,41266212,TTGTCAGGCTACCTTTTGCTCCATTTTCTGCTCACTCCTCCTAATGGCTTGGTGAAATAGCAAACAAGCCACCAGCAGGAATCTAGTCTGGATGACTGCTTCTGGAGCCTGGATGCAGTACCATTCTTCCACTGATTCAGTGAGTAACTGTTAGGTGGTTCCCTAAGGGATTAGGTATTTCATCACTGAGCTAACCCTGGCTATCATTCTGCTTTTCTTGGCTGTCTTTCAGATTTGACTTTATTTCTAAAAATATTTCAATGGGTCATATCACAGATTCTTTTTTTTTAAATTAAAGTAACATTTCCAATCTACTAATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAACAGGGATT,-	ENST00000349496	ENST00000349496.5:c.13+104_211del	p.X5_splice	Splice_Site	p.A5_F70del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
CTNNB1	Deletions flanking exon 2-3 (e.g. 3:41265579_41266277del)	splice, intron	Complete exon 3 skip or inframe deletion in exon 3	Recurrent alteration in CRC	3:g.41265990_41266204del	3,41265990,41266204,AATGCTAATACTGTTTCGTATTTATAGCTGATTTGATGGAGTTGGACATGGCCATGGAACCAGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAGGCAATCCTGAGGAAGAGGATGTGGATACCTCCCAAGTCCTGTATGAGTGGGAA,-	ENST00000349496	ENST00000349496.5:c.14-27_201del	p.X5_splice	Splice_Site	p.A5_Q68del	Splice_Exon_Shortening_In_Frame	In_Frame_Del		TRUE			29316426	Yaeger et al., 2018
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411926_116412083del	7,116411926,116412083,TACGATGCAAGAGTACACACTCCTCATTTGGATAGGCTTGTAAGTGCCCGAAGTGTAAGCCCAACTACAGAAATGGTTTCAAATGAATCTGTAGACTACCGAGCTACTTTTCCAGAAGGTATATTTCAGTTTATTGTTCTGAGAAATACCTATACATA,-	ENST00000397752	ENST00000397752.3:c.2914_3028+43del	p.X972_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			27343443	Schrock et al., 2014
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411770_116412349del	7,116411770,116412349,AGATTGTCGTCGATTCTTGTGTGCTGTCTTATATGTAGTCCATAAAACCCATGAGTTCTGGGCACTGGGTCAAAGTCTCCTGGGGCCCATGATAGCCGTCTTTAACAAGCTCTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCGCTACGATGCAAGAGTACACACTCCTCATTTGGATAGGCTTGTAAGTGCCCGAAGTGTAAGCCCAACTACAGAAATGGTTTCAAATGAATCTGTAGACTACCGAGCTACTTTTCCAGAAGGTATATTTCAGTTTATTGTTCTGAGAAATACCTATACATATACCTCAGTGGGTTGTGACATTGTTGTTTATTTTTGGTTTTGCATTTATATTTTTATAAAAACCTAAAGGAAGTATTTACCTCTGCCAAGTAAGTATTTGACACAAAATTACATGGCTCTTAATTTTAAAAGAACCCATGTATATATTACATTATGATTTTAGAGTCCATAAGCTCTCATTTCACAAAAAGGTTAATTTGAGCAAAAGTAATTTGTTTATCATCTAAGTGCAATAGTAAGAAATTGCGAAGCTCTCTTTTACAATC,-	ENST00000397752	ENST00000397752.3:c.2887+62_3028+306del	p.X963_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			27343443	Schrock et al., 2014
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411818_116412557del	7,116411818,116412557,CCATGAGTTCTGGGCACTGGGTCAAAGTCTCCTGGGGCCCATGATAGCCGTCTTTAACAAGCTCTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCGCTACGATGCAAGAGTACACACTCCTCATTTGGATAGGCTTGTAAGTGCCCGAAGTGTAAGCCCAACTACAGAAATGGTTTCAAATGAATCTGTAGACTACCGAGCTACTTTTCCAGAAGGTATATTTCAGTTTATTGTTCTGAGAAATACCTATACATATACCTCAGTGGGTTGTGACATTGTTGTTTATTTTTGGTTTTGCATTTATATTTTTATAAAAACCTAAAGGAAGTATTTACCTCTGCCAAGTAAGTATTTGACACAAAATTACATGGCTCTTAATTTTAAAAGAACCCATGTATATATTACATTATGATTTTAGAGTCCATAAGCTCTCATTTCACAAAAAGGTTAATTTGAGCAAAAGTAATTTGTTTATCATCTAAGTGCAATAGTAAGAAATTGCGAAGCTCTCTTTTACAATCCAGGAAGAGTTAAGTTACAAAATATACTTATTTAAATGTAAGTTGGAACTGCTACATTTTTTACCTGTTGAAGCCCAAACATTGAAATTATACTGTTAGTAATTCTTCGAAGTGTTTTCAATGAACTGTTAGTACACAGCCTTTTTCCCACCATATTCTAGGACTTGAATGTATTTTGAGACTTAGCCAAGGAAAACCTTCAATTATG,-	ENST00000397752	ENST00000397752.3:c.2888-79_3028+520del	p.X963_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			27343443	Schrock et al., 2014
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411874_116411897del	7,116411874,116411897,ACAAGCTCTTTCTTTCTCTCTGTT,-	ENST00000397752	ENST00000397752.3:c.2888-29_2888-6del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411881_116411897del	7,116411881,116411897,CTTTCTTTCTCTCTGTT,-	ENST00000397752	ENST00000397752.3:c.2888-22_2888-6del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411881_116411937del	7,116411881,116411937,CTTTCTTTCTCTCTGTTTTAAGATCTGGGCAGTGAATTAGTTCGCTACGATGCAAGA,-	ENST00000397752	ENST00000397752.3:c.2888-22_2922del	p.X963_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411860_116411888del	7,116411860,116411888,GATAGCCGTCTTTAACAAGCTCTTTCTTT,-	ENST00000397752	ENST00000397752.3:c.2888-43_2888-15del	p.*963*	Intron	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411879_116411896del	7,116411879,116411896,CTCTTTCTTTCTCTCTGT,-	ENST00000397752	ENST00000397752.3:c.2888-24_2888-7del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116412046A>G	7,116412046,116412046,A,G	ENST00000397752	ENST00000397752.3:c.3028+3A>G	p.X1010_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411879_116411897del	7,116411879,116411897,CTCTTTCTTTCTCTCTGTT,-	ENST00000397752	ENST00000397752.3:c.2888-24_2888-6del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411887_116411906del	7,116411887,116411906,TTCTCTCTGTTTTAAGATCT,-	ENST00000397752	ENST00000397752.3:c.2888-16_2891del	p.X963_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116412043G>A	7,116412043,116412043,G,A	ENST00000397752	ENST00000397752.3:c.3028G>A	p.D1010N	Missense_Mutation	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411885_116411897del	7,116411885,116411897,CTTTCTCTCTGTT,-	ENST00000397752	ENST00000397752.3:c.2888-18_2888-6del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116412041_116412044del	7,116412041,116412044,AAGG,-	ENST00000397752	ENST00000397752.3:c.3026_3028+1del	p.X1009_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411881_116411895del	7,116411881,116411895,CTTTCTTTCTCTCTG,-	ENST00000397752	ENST00000397752.3:c.2888-22_2888-8del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411867_116411882del	7,116411867,116411882,GTCTTTAACAAGCTCT,-	ENST00000397752	ENST00000397752.3:c.2888-36_2888-21del	p.*963*	Intron	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116412044G>A	7,116412044,116412044,G,A	ENST00000397752	ENST00000397752.3:c.3028+1G>A	p.X1010_splice	Splice_Site	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411876_116411896del	7,116411876,116411896,AAGCTCTTTCTTTCTCTCTGT,-	ENST00000397752	ENST00000397752.3:c.2888-27_2888-7del	p.X963_splice	Splice_Region	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
MET	Indels and substitutions flanking exon 14 (e.g. 7:116411926_116412083del)	splice	Skipping of exon 14	Actionable in NSCLC	7:g.116411867_116411890del	7,116411867,116411890,GTCTTTAACAAGCTCTTTCTTTCT,-	ENST00000397752	ENST00000397752.3:c.2888-36_2888-13del	p.*963*	Intron	p.D963_D1010del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			0	Confirmed by MSK Clinical Bioinformatics Team (Unpublished)
PIK3R1	Indels and substitutions flanking exon 11 (e.g. 5:67589663G>A)	splice	Skipping of exon 11	Recurrent in breast and uterine cancer	5:g.67589663G>C	5,67589663,67589663,G,C	ENST00000521381	ENST00000521381.1:c.1425+1G>C	p.X475_splice	Splice_Site	p.D434_E476del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			25488983	Lucas et al., 2014
PIK3R1	Indels and substitutions flanking exon 11 (e.g. 5:67589663G>A)	splice	Skipping of exon 11	Recurrent in breast and uterine cancer	5:g.67589663G>A	5,67589663,67589663,G,A	ENST00000521381	ENST00000521381.1:c.1425+1G>A	p.X475_splice	Splice_Site	p.D434_E476del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			25488983	Lucas et al., 2014
FLT3	Indels around tyrosine kinase (e.g. 13:28608214_28608215insTT...)	splice	Internal Tandem Duplication	Recurrent alteration in AML	13:g.28608217_28608218insCCAAACTCTAAATTTTCTCTTGGAAACTCCCATTTGAGATCATATTCATATTCTCTG	13,28608217,28608218,-,CCAAACTCTAAATTTTCTCTTGGAAACTCCCATTTGAGATCATATTCATATTCTCTG	ENST00000241453	ENST00000241453.7:c.1782_1837+1dup	p.X594_splice	Splice_Site	p.E598_F612dup	Splice_Exon_Extension_In_Frame	In_Frame_Ins		FALSE			31285539	Zhang et al., 2020
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108115753G>A	11,108115753,108115753,G,A	ENST00000278616	ENST00000278616.4:c.901G>A	p.G301S	Missense_Mutation	p.C222Qfs*2	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108127067G>A	11,108127067,108127067,G,A	ENST00000278616	ENST00000278616.4:c.2250G>A	p.X750_splice	Splice_Region	p.I709_K750del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline	This heterozygous germline variant ATM c.2250G>A variant does not change the encoded amino acid of the ATM protein (p.Lys750=), however, it falls at the last base pair of exon 14 of ATM. This variant has been identified in <0.01% of Non-Finnish European chromosomes in the genome Aggregation Database (http://gnomad.broadinstitute.org). It has been reported in combination with another pathogenic variant in individuals and families with Ataxia-telangiectasia (PMID: 9463314, 10980530, 9887333, 10330348, 19691550). It has also been reported in the heterozygous state in a BRCA1/2 negative individual undergoing multigene panel testing (PMID:26270727). An experimental study showed that this variant affects splicing and leads to exon skipping of exon 14 (PMID: 9887333). This variant is classified as pathogenic. ATM truncating mutations may increase the risk of breast cancer and pancreatic cancer (PMID: 21787400; PMID: 22585167) and have been reported in families with familial prostate cancer (PMID: 24556621.). Ataxia-telangiectasia is an autosomal recessive condition characterized by progressive cerebellar ataxia, telangiectasias, immunodeficiency, and increased cancer risks and is caused by two mutations (one affecting each allele) in the ATM gene. If an ATM mutation carrier's partner is heterozygous for a pathogenic ATM mutation, there is a 25% risk that each child would be affected by ataxia-telangiectasia.	9887333;31843900	Sandoval et al., 1999;Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108138071T>C	11,108138071,108138071,T,C	ENST00000278616	ENST00000278616.4:c.2638+2T>C	p.X880_splice	Splice_Site	p.A823Vfs*5	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108175400A>C	11,108175400,108175400,A,C	ENST00000278616	ENST00000278616.4:c.5497-2A>C	p.X1833_splice	Splice_Site	p.V1833Ifs*63	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108198370A>C	11,108198370,108198370,A,C	ENST00000278616	ENST00000278616.4:c.6976-2A>C	p.X2326_splice	Splice_Site	p.N2326_K2363del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108198484_108198522del	11,108198484,108198522,AGGTAAGATTTTTGGAGCAACCCTTAAGATAGTTACTTA,-	ENST00000278616	ENST00000278616.4:c.7088_7089+37del	p.X2363_splice	Splice_Site	p.N2326_K2363del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108214099_108214103del	11,108214099,108214103,GTGAG,-	ENST00000278616	ENST00000278616.4:c.8418+1_8418+5del	p.X2806_splice	Splice_Site	p.V2757_M2806del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108236051G>A	11,108236051,108236051,G,A	ENST00000278616	ENST00000278616.4:c.8988-1G>A	p.X2996_splice	Splice_Site	p.S2996Rfs*5	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		TRUE	germline		31843900	Casadei et al., 2019
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108202764G>A	11,108202764,108202764,G,A	ENST00000278616	ENST00000278616.4:c.7788G>A	p.X2596_splice	Splice_Region	p.L2544_E2596del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline	This heterozygous ATM c.7788G>A p.Glu2596Glu variant is a synonymous variant that occurs at the last nucleotide of exon 52 and does not alter the amino acid at this position. It has been identified in 0.002% of Non-Finnish European chromosomes by the Exome Aggregation Consortium (ExAC: http://exac.broadinstitute.org; dbSNP). This variant has been reported in two homozygous and one compound heterozygous individuals with ataxia-telangiectasia (PMID: 9792409 and 26693373). It has been demonstrated to cause altered splicing, leading to deletion of 53 amino acids in exon 52 (PMID: 9792409). This region includes part of the FAT domain, which has been suggested to be important for proper activity of the protein (PMID: 23532176, 25460276, 10782091, 27229179). In summary, based on the previous reports of this variant in individuals with ataxia-telangiectasia and its impact on the protein, this variant meets our criteria to be classified as pathogenic. ATM truncating mutations may increase the risk of breast cancer and pancreatic cancer (PMID: 21787400; PMID: 22585167) and have been reported in families with familial prostate cancer (PMID: 24556621.) Ataxia-telangiectasia is an autosomal recessive condition characterized by progressive cerebellar ataxia, telangiectasias, immunodeficiency, and increased cancer risks and is caused by two mutations (one affecting each allele) in the ATM gene. If an ATM mutation carrier's partner is heterozygous for a pathogenic ATM mutation, there is a 25% risk that each child would be affected by ataxia-telangiectasia.	9792409	Broeks et al., 1998
ATM	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to exon skip, frameshift and inframe deletion	In ataxia telangiectasia and familial prostate cancer, increase the risk of breast and pancreatic cancer	11:g.108151895G>A	11,108151895,108151895,G,A	ENST00000278616	ENST00000278616.4:c.3576G>A	p.X1192_splice	Splice_Region	p.S1135_K1192	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline	This heterozygous ATM c.3576G>A variant is a synonymous alteration that does not change a Lysine to another amino acid at codon 1192 (p.Lys1192=). This variant occurs in the last nucleotide of an exon and leads to aberrant splicing leading to exon skipping according to in-vitro RNA studies (PMID: 9887333, 16941484, 21965147). This variant has been identified in 4/113572 of Non-Finnish European chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org/;), and has been reported in multiple individuals with ataxia telangiectasia in heterozygous (in-trans with another pathogenic ATM variant) or homozygous states (PMID: 30819809, 8845835, 9443866, 9792409, 9887333, 10330348, 12552559, 16941484, 17124347). Furthermore, this variant has been detected in patients with breast, thyroid or ampullary cancers (PMID: 27599564, 30620386, 31300551). In summary, based on the previous reports of this variant in individuals with ATM associated disease and in-vitro functional studies, this variant is classified as pathogenic. ATM truncating mutations may increase the risk of breast cancer and pancreatic cancer (PMID: 21787400; PMID: 22585167) and have been reported in families with familial prostate cancer (PMID: 24556621.) Ataxia-telangiectasia is an autosomal recessive condition characterized by progressive cerebellar ataxia, telangiectasias, immunodeficiency, and increased cancer risks and is caused by two mutations (one affecting each allele) in the ATM gene. If an ATM mutation carrier's partner is heterozygous for a pathogenic ATM mutation, there is a 25% risk that each child would be affected by ataxia-telangiectasia.	9887333;16941484;21965147	Sandoval et al., 1999;Cavalieri et al., 2006;Demuth et al., 2011
BRCA1	Mutations at canonical splice sites predicted to alter splicing	missense, splice, intron	Splice leads to frameshift		17:g.41197820C>T	17,41197820,41197820,C,T	ENST00000357654	ENST00000357654.3:c.5468-1G>A	p.X1823_splice	Splice_Site	p.A1844Dfs*2	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
BRCA1	Mutations at canonical splice sites predicted to alter splicing	missense, splice, intron	Splice leads to frameshift		17:g.41228505C>A	17,41228505,41228505,C,A	ENST00000357654	ENST00000357654.3:c.4484G>T	p.R1495M	Missense_Mutation	p.A1453Gfs*9	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
BRCA1	Mutations at canonical splice sites predicted to alter splicing	missense, splice, intron	Splice leads to deletion of 22 bp at the end of exon 5		17:g.41258474T>C	17,41258474,41258474,T,C	ENST00000357654	ENST00000357654:c.211A>G	p.R71G	Missense_Mutation	p.C64*	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE		The BRCA1 c.211A>G variant changes an arginine to glycine at codon 71 (p.R71G). This variant has been identified in 1/249744 chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org/), and has been reported as a founder mutation in the Spanish population shown to segregate with breast and ovarian cancer in multiple families (PMID: 11385711, 23683081, 27081505, 12014998, 20215541). According to RT-PCR analysis, this variants leads to an aberrantly spliced mRNA creating a premature stop codon (p.Cys64*) (PMID: 11385711, 19123044, 20215541, 21735045). Heterozygous truncating variants in BRCA1 are known to be pathogenic. Note: this variant is also known as 330A>G in the literature. The sequence analysis indicated that 22 base pairs of exon 4 were deleted, creating with the first bases of exon 5, a termination codon at position 64	21735045;11385711	Menéndez et al., 2012;Vega et al., 2001
BRCA1	Mutations at canonical splice sites predicted to alter splicing	missense, splice, intron	Splice leads to deletion of 22 bp at the end of exon 5		17:g.41258472C>T	17,41258472,41258472,C,T	ENST00000357654	ENST00000357654:c.212+1G>A	p.X71_splice	Splice_Site	p.C64*	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE		Deletion of 22 bp at the end of exon 4	21735045	Menéndez et al., 2012
BRCA1	Mutations predicted to alter splicing	missense, splice, intron	Splice leads to insertion of 11 bp of intro 4 at the beginning of exon 5		17:g.41256985T>C	17,41256985,41256985,T,C	ENST00000357654	ENST00000357654:c.213-12A>G	p.*71*	Intron	p.R71Sfs*20	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins		FALSE		Insertion of 11 bp of intro 4 at the beginning of exon 5	21735045	Menéndez et al., 2012
BRCA1	Mutations predicted to alter splicing	missense, splice, intron	Splice leads to skipping of exon 12		17:g.41234420C>A	17,41234420,41234420,C,A	ENST00000357654	ENST00000357654:c.4357+1G>T	p.X1453_splice	Splice_Site	p.R1397Yfs*2	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del	Deletion of the first three bases of exon 14 (r.4358_4360del), leading to an in-frame deletion of the amino acid alanine at codon 1,453 (p.Ala1453del)	FALSE		Skipping of exon 12	21735045	Menéndez et al., 2012
BRCA1	Mutations predicted to alter splicing	missense, splice, intron	Splice leads to skipping of exon 12 and deletion of G		17:g.41234420del	17,41234420,41234420,C,-	ENST00000357654	ENST00000357654:c.4357+1delG	p.X1453_splice	Splice_Site	p.A1453Qfs*3	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del	Can also be a a skipping of exon 13, although in the case of c.4357+1delG this aberrant band is observed in a lower proportion; this frameshift deletion is predicted to generate a premature stop codon (p.Arg1397TyrfsX2)	FALSE		Deletion of a guanine at the last base of exon 12 (r.4357del) because of the use of a cryptic donor splice site created by the DNA mutation	21735045	Menéndez et al., 2012
BRCA1	Mutations predicted to alter splicing	missense, splice, intron	Splice leads to skipping of exon 13		17:g.41228504C>A	17,41228504,41228504,C,A	ENST00000357654	ENST00000357654:c.4484+1G>T	p.X1495_splice	Splice_Site	p.A1453Gfs*10	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE		This mutation arises in the invariant guanine in the consensus sequence of the 5' donor splice site of exon 13. cDNA analysis showed that this mutation abolishes the natural 5_ splice site of exon 13, causing complete deletion of this exon (r.4358_4484del)	21735045	Menéndez et al., 2012
BRCA1	Mutations predicted to alter splicing	missense, splice, intron	Splice leads to skipping of exon 16 and insertion of 153 bp of intron 16		17:g.41219622T>C	17,41219622,41219622,T,C	ENST00000357654	ENST00000357654:c.5074+3A>G	p.*1692*	Splice_Region	p.D1692Gfs*15	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Ins	Can also be a skipping of exon 17 (r.4987_5074del), which is predicted to lead to the truncated proteins p.Val1665SerfsX8	FALSE		The BRCA1 c.5074+3A>G variant was identified in a woman with bilateral breast cancer; her mother, who was diagnosed with breast cancer at age 53 and with colorectal cancer at age 68, carried the same variant. RNA analysis of this variant shows an insertion of the first 153 bp of intron 16 (r.5074_5075ins5074+1_5074+153). the pathogenicity of this mutation may derive from the splicing anomalies detected and is supported by the co-segregation with breast cancer observed in this family.	21735045	Menéndez et al., 2012
BRCA2	Mutations at canonical splice sites predicted to alter splicing	splice, intron	Splice leads to frameshift		13:g.32900634A>G	13,32900634,32900634,A,G	ENST00000380152	ENST00000380152.3:c.517-2A>G	p.X173_splice	Splice_Site	p.G173Sfs*17	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
BRCA2	Mutations at canonical splice sites predicted to alter splicing	splice, intron	Splice leads to frameshift		13:g.32931878G>A	13,32931878,32931878,G,A	ENST00000380152	ENST00000380152.3:c.7618-1G>A	p.X2540_splice	Splice_Site	p.L2540Qfs*10	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
BRCA2	Mutations at canonical splice sites predicted to alter splicing	splice, intron	Splice leads to frameshift		13:g.32954050G>A	13,32954050,32954050,G,A	ENST00000380152	ENST00000380152.3:c.9117G>A	p.X3039_splice	Splice_Region	p.V2985Gfs*3	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
BRCA2	c.6937+594T>G	splice, intron	Mutation in deep intron region creates a cryptic exon between exon 12 and 13	Found in patients with breast and ovarian cancer family history	13:g.32919384T>G	13,32919384,32919384,T,G	ENST00000380152	ENST00000380152.3:c.6937+594T>G	p.*2313*	Intron	p.G2313Gfs*9	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins		FALSE			22753590	Anczuków et al., 2012
BRCA2	c.517-1G>A	splice, intron, missense	Splice leads to exon 7 skip		13:g.32900635G>A	13,32900635,32900635,G,A	ENST00000380152	ENST00000380152.3:c.517-1G>A	p.X173_splice	Splice_Site	p.G173Sfs*19	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del	Activate a cryptic donor splice site that leads to the skipping of most of exon 6 and all of exon 7 (r.478_631del). This transcript is predicted to lead to a truncated protein (p.Val160SerfsX19) 	FALSE		Leads to a skipping of exon 7 (r.517_631del)	21735045	Menéndez et al., 2012
BRCA2	c.1763A>G	splice, intron, missense	Splice leads to frameshift delins		13:g.32907378A>G	13,32907378,32907378,A,G	ENST00000380152	ENST00000380152.3:c.1763A>G	p.N588S	Missense_Mutation	p.N588_G637delinsS	Splice_Exon_Shortening_In_Frame	In_Frame_Del		FALSE		Identified in a woman diagnosed with breast cancer at age 31. This variant creates a new cryptic donor site, which leads to an alternative transcript consisting of an in-frame deletion of 147 nucleotides (r.1763_1909del) that, in turn, produces an in-frame deletion of 49 amino acids with the insertion of a serine (p.Asn588_Gly637delinsSer)	21735045	Menéndez et al., 2012
BRCA2	c.8332-1G>A	splice, intron, missense	Splice leads to frameshift delins		13:g.32944538G>A	13,32944538,32944538,G,A	ENST00000380152	ENST00000380152.3:c.8332-1G>A	p.X2778_splice	Splice_Site	p.I2778Yfs*15	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE		This mutation arises in the invariant dinucleotide in the consensus sequence of the 3_ acceptor splice site of exon 19. cDNA analysis of the mutation showed that this mutation abolishes the natural 3_ splice site of exon 19 and leads to the activation of a cryptic splice site 14 bp downstream. Consequently, the mutated transcript shows a 14-bp deletion at the beginning of exon 19 (r.8332_8345del).	21735045	Menéndez et al., 2012
BRCA2	c.8954-15T>G	splice, intron, missense	Splice leads to frameshift delins		13:g.32953872T>G	13,32953872,32953872,T,G	ENST00000380152	ENST00000380152.3:c.8954-15T>G	p.*2985*	Splice_Region	p.V2985Afs*8	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins		FALSE		It creates a new cryptic donor site that leads to an alternative transcript with an insertion of the last 14 nucleotides of intron 22 (r.8953_8954ins8954-14_8954-1), generating a truncated protein (p.Val2985AlafsX8). Segregation analysis showed that the two sisters with breast cancer (diagnosed at 29 and 40 years old, respectively) are carriers of this variant, which was inherited from their unaffected father whose history is non-informative of HBOCS.	21735045	Menéndez et al., 2012
BRCA2	c.8954-5A>G	splice, intron, missense	Splice leads to frameshift delins		13:g.32953882A>G	13,32953882,32953882,A,G	ENST00000380152	ENST00000380152.3:c.8954-5A>G	p.X2985_splice	Splice_Region	p.V2985Dfs*34	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins		FALSE		It creates a novel cryptic donor site that leads to an alternative transcript with an insertion of the last four nucleotides of intron 22 (r.8953_8954ins8954-4_8954-1), generating a truncated protein (p.Val2985AspfsX34). The variant was observed in a young female patient with metachronic bilateral cancer diagnosed at 36 and 42 years who has no relative affected by tumors associated with HBOCS.	21735045	Menéndez et al., 2012
BRIP1	Mutations at canonical splice sites predicted to alter splicing	splice	Skip exon 5	Reported in individuals with breast and ovarian cancers	17:g.59926490C>T	17,59926490,59926490,C,T	ENST00000259008	ENST00000259008.2:c.507G>A	p.X169_splice	Splice_Region	p.D127Dfs*1	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		TRUE	germline	This silent sequence change affects codon 169 of the BRIP1 mRNA and does not change the encoded amino acid sequence (p.Gln169=). This variant falls at the last nucleotide of BRIP1 exon 5. This variant is absent from large population databases (1000 Genomes, ESP, and gnomAD), and has been reported in the literature in individuals with breast and ovarian cancers (PMID: 29368626). An experimental study using patient RNA showed that this variant led to skipping of exon 5 and a prematurely truncated protein product (PMID: 29368626). In summary, although additional studies are required to fully establish its clinical significance, this BRIp1 c.507G>A p.Gln169= variant is classified as likely pathogenic. Heterozygous pathogenic variants in BRIP1 have been associated with an increased risk of ovarian cancer (PMID: 26315354, 2196457) and may increase the risk of breast cancer (PMID: 17033622). Biallelic mutations in BRIP1 have been associated with Fanconi Anemia, an autosomal recessive condition characterized by physical abnormalities, bone marrow failure, and increased risk of malignancy. If a BRIP1 mutation carrier's partner is heterozygous for a pathogenic BRIP1 mutation, there is a 25% risk that each child would be affected by Fanconi Anemia.	29368626	Weber-Lassalle et al., 2018
BRIP1	Mutations at canonical splice sites predicted to alter splicing	splice	Skip exon 5	Reported in individuals with breast and ovarian cancers	17:g.59938807C>T	17,59938807,59938807,C,T	ENST00000259008	ENST00000259008.2:c.93+1G>A	p.X31_splice	Splice_Site	p.M1_S31del	Splice_Exon_Skip_Non_Start	In_Frame_Del		FALSE	germline		31843900	Casadei et al., 2019
CDH1	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to frameshift(exon 11) and nonsense(exon 10)		16:g.68849663G>A	16,68849663,68849663,G,A	ENST00000261769	ENST00000261769.5:c.1565+1G>A	p.X522_splice	Splice_Site	p.T523*	Splice_Exon_Extension_Nonsense	Nonsense_Mutation		FALSE	germline		31843900	Casadei et al., 2019
CDH1	Last nucleotide of exon 7	splice	Altered the exon 7 boundary, producing 7 bp insertions of the intron sequences	Reported in an individual affected with diffuse gastric cancer	16:g.68845762G>A	16,68845762,68845762,G,A	ENST00000261769	ENST00000261769.5:c.1008G>A	p.X336_splice	Splice_Region	p.S337Vfs*14	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins	Can also be 25, 42, 150 bp intron 7 insertion, and whole intron 7 insertions	FALSE		The heterozygous germline variant, CDH1 c.1008G>A (p.Glu336=) is located at the last nucleotide of exon 7 of the CDH1 gene. This variant is absent from large population databases (1000 Genomes, ESP, and gnomAD) and has been reported in an individual affected with diffuse gastric cancer (PMID: 27730413). Experimental studies and analysis of RNA demonstrated that this variant leads to aberrant splicing (PMID: 8127895, 18427545). Additionally, a different variant at this position (c.1008G>T) has been reported in a family affected with hereditary diffuse gastric cancer (PMID: 9537325, 19725995). In summary, although additional studies are required to fully establish its clinical significance, this c.1008G>A variant is classified as likely pathogenic.	8127895;18427545	Oda et al., 1994;Karam et al., 2008
CDH1	Mutations at canonical splice sites predicted to alter splicing	missense, splice	Splice leads to frameshift(exon 11) and nonsense(exon 10)		16:g.68853328G>A	16,68853328,68853328,G,A	ENST00000261769	ENST00000261769.5:c.1711G>A	p.G571S	Missense_Mutation	p.Y523Ffs*15	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
CHEK2	Mutations at canonical splice sites predicted to alter splicing	splice	Splice leads to frameshift		22:g.29121230C>T	22,29121230,29121230,C,T	ENST00000328354	ENST00000328354.6:c.444+1G>A	p.X148_splice	Splice_Site	p.E149Ifs*5	Splice_Exon_Extension_Frame_Shift	Frame_Shift_Ins		FALSE	germline		31843900	Casadei et al., 2019
PALB2	Mutations at canonical splice sites predicted to alter splicing	splice	Splice leads to exon 9 or exon 6 skipping		16:g.23634452C>G	16,23634452,23634452,C,G	ENST00000261584	ENST00000261584.4:c.2835-1G>C	p.X945_splice	Splice_Site	p.A946_G999del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE	germline		31843900	Casadei et al., 2019
PALB2	Mutations at canonical splice sites predicted to alter splicing	splice	Splice leads to exon 9 or exon 6 skipping		16:g.23640597C>A	16,23640597,23640597,C,A	ENST00000261584	ENST00000261584.4:c.2515-1G>T	p.X839_splice	Splice_Site	p.T839_K862del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE	germline		31843900	Casadei et al., 2019
RAD51D	Mutations at canonical splice sites predicted to alter splicing	splice	Splice leads to frameshift exon truncation		17:g.33428057T>A	17,33428057,33428057,T,A	ENST00000590016	ENST00000590016.1:c.964-2A>T	p.X302_splice	Splice_Site	p.P322Vfs*5	Splice_Exon_Shortening_Frame_Shift	Frame_Shift_Del		FALSE	germline		31843900	Casadei et al., 2019
MLH1	Last nucleotide of exon 15;Alterations on the ESE motifs cause deletion of exons	splice	Skipping of exon 15 and leads to an out-of-frame transcript and premature protein truncation; Alters number of ESEs affecting transcription	In Lynch syndrome colorectal cancer and multiple cancer types	3:g.37083822G>A	3,37083822,37083822,G,A	ENST00000231790	ENST00000231790.2:c.1731G>A	p.X577_splice	Splice_Region	p.S556Rfs*13	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		TRUE	germline	The heterozygous germline variant, MLH1 c.1731G>A (p.Ser577Ser), results in a silent mutation and occurs at the last nucleotide of exon 15. This variant is absent from the major population databases (1000G, ESP and gnomAD). It is a well known pathogenic variant that has been reported in several individuals and families with Lynch syndrome (PMID: 16341550, 15849733, 20223024, 26300997, 14635101, 16216036, 16395668, 19669161). Experimental studies using mRNA isolated from patients blood as well as a reporter minigene assay showed that this variant results in the skipping of exon 15 and leads to an out-of-frame transcript and premature protein truncation (PMID: 16341550, 18561205, 16451135). In summary, based on the previous reports of this variant in individuals with MLH1 associated cancers and its truncating effect on the protein, this variant meets our criteria to be classified as pathogenic. Lynch syndrome is an autosomal dominant condition that confers an increased risk for colorectal cancer and endometrial cancers as well as other cancers. There is a 50% chance that each child would inherit this variant from a carrier parent.	16341550;18561205;16451135	Pagenstecher et al., 2006;Tournier et al., 2008;Kurzawski et al., 2006
MLH1	Last nucleotide of exon 15;Alterations on the ESE motifs cause deletion of exons	splice	Skipping of exon 15 and leads to an out-of-frame transcript and premature protein truncation; Alters number of ESEs affecting transcription	In Lynch syndrome colorectal cancer and multiple cancer types	3:g.37059048C>T	3,37059048,37059048,C,T	ENST00000231790	ENST00000231790.2:c.842C>T	p.A281V	Missense_Mutation	p.H264Lfs*2	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE		Alterations on the ESE motifs cause deletion of exons, affects splicing across multiple cancer types	16995940	Lastella et al., 2006
MLH1	Last nucleotide of exon 15;Alterations on the ESE motifs cause deletion of exons	splice	Skipping of exon 15 and leads to an out-of-frame transcript and premature protein truncation; Alters number of ESEs affecting transcription	In Lynch syndrome colorectal cancer and multiple cancer types	3:g.37090087G>C	3,37090087,37090087,G,C	ENST00000231790	ENST00000231790.2:c.1976G>C	p.R659P	Missense_Mutation	p.E633_E663del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE		Alterations on the ESE motifs cause deletion of exons, affects splicing across multiple cancer types	16995940	Lastella et al., 2006
MLH1	Last nucleotide of exon 15;Alterations on the ESE motifs cause deletion of exons	splice	Skipping of exon 15 and leads to an out-of-frame transcript and premature protein truncation; Alters number of ESEs affecting transcription	In Lynch syndrome colorectal cancer and multiple cancer types	3:g.37050394C>T	3,37050394,37050394,C,T	ENST00000231790	ENST00000231790.2:c.543C>T	p.X181_splice	Splice_Region	p.G181Gfs*20	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		28334867	Yamaguchi et al., 2017
MLH1	c.546-2A>G	splice	Skipping of exon 7	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	3:g.37053309A>G	3,37053309,37053309,A,G	ENST00000231790	ENST00000231790.2:c.546-2A>G	p.X182_splice	Splice_Site	p.R84Sfs*5	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		16451135	Kurzawski et al., 2006
MLH1	c.677G>T	missense	Skipping of exon 8	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	3:g.37053590G>T	3,37053590,37053590,G,T	ENST00000231790	ENST00000231790.2:c.677G>T	p.R226L	Missense_Mutation	p.Q197Rfs*7	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		12362047;16451135	Kurzawski et al., 2002;Kurzawski et al., 2006
MLH1	c.883A>C	missense	Skipping of exon 10	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	3:g.37059089A>C	3,37059089,37059089,A,C	ENST00000231790	ENST00000231790.2:c.883A>C	p.S295R	Missense_Mutation	p.H264Lfs*1	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		12362047;16451135	Kurzawski et al., 2002;Kurzawski et al., 2006
MLH1	c.1409+1G>C	splice	Skipping of exon 12	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	3:g.37067499G>C	3,37067499,37067499,G,C	ENST00000231790	ENST00000231790.2:c.1409+1G>C	p.X470_splice	Splice_Site	p.T347Kfs*7	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		12362047;16451135	Kurzawski et al., 2002;Kurzawski et al., 2006
EGFR	5 bases upstream from the 5' end of exon 20 (7:g.55248980_55248981insTCCAGGAAGCCT)	splice	Inset a repeated sequence from 55248980-55248992	Recurrent in lung cancer, can be linked to Level 1 TKIs	7:g.55248980_55248981insTCCAGGAAGCCT	7,55248980,55248981,-,TCCAGGAAGCCT	ENST00000275493	ENST00000275493.2:c.2284-5_2290dup	p.X762_splice	Splice_Region	p.A763_Y764insFQEA	Splice_Exon_Extension_In_Frame	In_Frame_Ins		TRUE			31715539	Sousa et al., 2020
TP53	c.375+5G mutations flanking exon 4	splice	Splice leads to whole exon 4 skipping inframe deletion or partial exon 4 skipping frameshift	Recurrent in many cancer types and results in P53 protein loss of function	17:g.7579307C>A	17,7579307,7579307,C,A	ENST00000269305	ENST00000269305.4:c.375+5G>T	p.X125_splice	Splice_Region	p.S33_T125del	Splice_Exon_Skip_In_Frame	In_Frame_Del	Partial exon 4 skip, p.G59Vfs*23, Splice_Exon_Shortening_Frame_Shift	TRUE			34505757	Chui et al., 2021
TP53	c.375G>T	splice	Splice leads to whole exon 4 skipping inframe deletion or partial exon 4 skipping frameshift	Recurrent in many cancer types and results in P53 protein loss of function	17:g.7579312C>A	17,7579312,7579312,C,A	ENST00000269305	ENST00000269305.4:c.375G>T	p.X125_splice	Splice_Region	p.S33_T125del	Splice_Exon_Skip_In_Frame	In_Frame_Del		TRUE	germline	The heterozygous germline variant, TP53 c.375G>T (Thr125=), is located at the last nucleotide of exon 4 of the TP53 gene. This variant is absent from large population databases (1000 Genomes, ESP, and gnomAD). It has been reported in a family with Li Fraumeni syndrome (PMID: 11420676). In vitro studies and analysis of RNA from patient cells demonstrated that this variant leads to aberrant splicing (PMID: 11420676, 25730903). Two other variants at this position (c.375G>A and c.375G>C) have been reported in individuals and families with Li Fraumeni syndrome (PMID: 9242456, 10864200, 11420676, 24382691, 31105275). In summary, although additional studies are required to fully establish its clinical significance, based on its previous report in an individual with Li Fraumeni syndrome and its demonstrated impact on splicing, this c.375G>T (p.?) variant is classified as likely pathogenic. Li-Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome associated with an increased risk of tumors including soft tissue sarcoma, osteosarcoma, pre-menopausal breast cancer, brain tumors, adrenocortical carcinoma (ACC), and leukemias (http://www.ncbi.nlm.nih.gov/books/NBK1311/).	11420676	Varley et al., 2001
F11	Alterations in Exon Splice Enhancement Sites (ESE) affecting multiple exons	missense	Alters number of ESEs affecting transcription and causing aberrant splicing	Largely found in cancer-related thrombosis	4:g.187208954G>A	4,187208954,187208954,G,A	ENST00000403665	ENST00000403665.2:c.1693G>A	p.E565K	Missense_Mutation	p.D526_G572del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			21718436	Zucker et al., 2011
F11	Alterations in Exon Splice Enhancement Sites (ESE) affecting multiple exons	missense	Alters number of ESEs affecting transcription and causing aberrant splicing	Largely found in cancer-related thrombosis	4:g.187201659G>A	4,187201659,187201659,G,A	ENST00000403665	ENST00000403665.2:c.1060G>A	p.G350R	Missense_Mutation	p.K343_E379del	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE			21718436	Zucker et al., 2011
F11	Alterations in Exon Splice Enhancement Sites (ESE) affecting multiple exons	missense	Alters number of ESEs affecting transcription and causing aberrant splicing	Largely found in cancer-related thrombosis	4:g.187197405C>T	4,187197405,187197405,C,T	ENST00000403665	ENST00000403665.2:c.616C>T	p.P206S	Missense_Mutation	p.A199_R252del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			21718436	Zucker et al., 2011
MSH2	Alterations on the ESE motifs cause skipping of exons	missense	Alters number of ESEs affecting transcription	Affects splicing across multiple cancer types	2:g.47641421C>T	2,47641421,47641421,C,T	ENST00000233146	ENST00000233146.2:c.806C>T	p.S269L	Missense_Mutation	p.V265_Q314del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			16995940	Lastella et al., 2006
MSH2	Alterations on the ESE motifs cause skipping of exons	missense	Alters number of ESEs affecting transcription	Affects splicing across multiple cancer types	2:g.47641430C>T	2,47641430,47641430,C,T	ENST00000233146	ENST00000233146.2:c.815C>T	p.A272V	Missense_Mutation	p.V265_Q314del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE			16995940	Lastella et al., 2006
MSH2	Alterations on the ESE motifs cause skipping of exons	missense	Alters number of ESEs affecting transcription	Affects splicing across multiple cancer types	2:g.47693802G>T	2,47693802,47693802,G,T	ENST00000233146	ENST00000233146.2:c.1516G>T	p.D506Y	Missense_Mutation	p.G504Afs*3	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE			16995940	Lastella et al., 2006
MSH2	Alterations on the ESE motifs cause skipping of exons	missense	Alters number of ESEs affecting transcription	Affects splicing across multiple cancer types	2:g.47693886C>T	2,47693886,47693886,C,T	ENST00000233146	ENST00000233146.2:c.1600C>T	p.R534C	Missense_Mutation	p.G504Afs*3	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE			16995940	Lastella et al., 2006
MSH2	c.942+3A>T mutation flanking exon 5	splice	Skipping of exon 5	Reported in families with colorectal cancer	2:g.47641560A>T	2,47641560,47641560,A,T	ENST00000233146	ENST00000233146.2:c.942+3A>T	p.X314_splice	Splice_Region	p.V265_Q314del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE	germline		33259954;12362047;16451135	Oldfield et al., 2021;Kurzawski et al., 2002;Kurzawski et al., 2006
MSH2	c.1661+5G>C	splice	Skipping of exon 10	Reported in families with colorectal cancer, potentially specific for Polish families	2:g.47693952G>C	2,47693952,47693952,G,C	ENST00000233146	ENST00000233146.2:c.1661+5G>C	p.*554*	Splice_Region	p.G504Afs*3	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		33259954;12362047;16451135	Oldfield et al., 2021;Kurzawski et al., 2002;Kurzawski et al., 2006
MSH2	c.645+1G>T	splice	Skipping of exon 3	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	2:g.47637512G>T	2,47637512,47637512,G,T	ENST00000233146	ENST00000233146.2:c.645+1G>T	p.X215_splice	Splice_Site	p.A123_Q215del	Splice_Exon_Skip_In_Frame	In_Frame_Del		FALSE	germline		12362047;16451135	Kurzawski et al., 2002;Kurzawski et al., 2006
MSH2	c.2210+1G>C	splice	Skipping of exon 13	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	2:g.47703711G>C	2,47703711,47703711,G,C	ENST00000233146	ENST00000233146.2:c.2210+1G>C	p.X737_splice	Splice_Site	p.G669Gfs*7	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		12362047;16451135	Kurzawski et al., 2002;Kurzawski et al., 2006
MSH2	c.2634+1G>A	splice	Skipping of exon 15 and leads to an out-of-frame transcript and premature protein truncation; Alters number of ESEs affecting transcription	In colorectal cancer or HNPCC-associated cancers (endometrium, small bowel, urinary tract) 	2:g.47708011G>A	2,47708011,47708011,G,A	ENST00000233146	ENST00000233146.2:c.2634+1G>A	p.X878_splice	Splice_Site	p.G820Afs*2	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE	germline		12362047;16451135	Kurzawski et al., 2002;Kurzawski et al., 2006
RB1	c.1206C>T mutation on exon 12	synonymous	Disrupting the splicing enhancer element and caused skipping of exon 12	Reported in an individual with unilateral retinoblastoma	13:g.48947619C>T	13,48947619,48947619,C,T	ENST00000267163	ENST00000267163.4:c.1206C>T	p.S402=	Silent	p.R376Rfs*4	Splice_Exon_Skip_Frame_Shift	Frame_Shift_Del		FALSE		This heterozygous RB1 c.1206C>T variant is a synonymous variant that does not alter the amino acid at this position (p.Ser402=). This variant has been identified in 3/30442 South Asian chromosomes by the Genome Aggregation Database (gnomAD: http://gnomad.broadinstitute.org). It has been reported in an individual with unilateral retinoblastoma and was demonstrated to cause abnormal splicing based on patient RNA studies (PMID 21763628). In our patient (DMG19-4863) with unilateral retinoblastoma, tumor analysis identified somatic biallelic mutations (two somatic hits) in RB1 (DMG internal data). In summary, based on the currently available data, the clinical significance of the RB1 c.1206C>T (p.Ser402=) variant is uncertain.	21763628	Ahani et al., 2011
TERT	−124 bp from the ATG start site in the TERT promoter	non-coding	Creates new Ets/TCF binding site, increases TERT expression	Found in many cancer types, such as glioma, bladder, thyroid, liver, melanoma	5:g.1295228G>A	5,1295228,1295228,G,A	ENST00000310581			5'Flank					FALSE	somatic	−124C > T (this mutation) and −146C > T are the most common mutations. In melanoma −146C > T mutation is more frequent than the −124C > T; in cancers, especially in gliomas, thyroid cancers and bladder cancers the latter is the most common mutation. 	24657534	Heidenreich et al., 2013
TERT	−146 bp from the ATG start site in the TERT promoter	non-coding	Creates new Ets/TCF binding site, increases TERT expression	Found in many cancer types, such as glioma, bladder, thyroid, liver, melanoma	5:g.1295250G>A	5,1295250,1295250,G,A	ENST00000310581			5'Flank					FALSE	somatic	−124C > T and −146C > T (this mutation) are the most common mutations. In melanoma −146C > T mutation is more frequent than the −124C > T; in cancers, especially in gliomas, thyroid cancers and bladder cancers the latter is the most common mutation. 	24657534	Heidenreich et al., 2013
TERT	−124 bp to -125 bp from the ATG start site in the TERT promoter	non-coding	Creates new Ets/TCF binding site, increases TERT expression	Found in many cancer types, such as glioma, bladder, thyroid, liver, melanoma	5:g.1295228_1295229delinsAA	5,1295228,1295229,GG,AA	ENST00000310581			5'Flank					FALSE	somatic	In melanoma two CC > TT tandem mutations affecting −124/−125 and −138/−139 residues were also detected with a combined frequency of 9%; this mutation augmented the evidence for the UV-origin of tumor specific nucleotide changes in melanoma	24657534	Heidenreich et al., 2013
TERT	−138 bp to -139 bp from the ATG start site in the TERT promoter	non-coding	Creates new Ets/TCF binding site, increases TERT expression	Found in bladder cancer	5:g.1295242_1295243delinsAA	5,1295242,1295243,GG,AA	ENST00000310581			5'Flank					FALSE	somatic	In melanoma two CC > TT tandem mutations affecting −124/−125 and −138/−139 residues were also detected with a combined frequency of 9%; this mutation augmented the evidence for the UV-origin of tumor specific nucleotide changes in melanoma	24657534	Heidenreich et al., 2013
TERT	−57 bp from the ATG start site in the TERT promoter	non-coding	Creates new Ets/TCF binding site, increases TERT expression	Found in patients with melanoma family history	5:g.1295161T>G	5,1295161,1295161,T,G	ENST00000310581			5'Flank					FALSE	germline	In a large melanoma pedigree where affected individuals presented a severe form of the disease with an early age of onset. The germline mutation was present in affected and absent in unaffected individuals in the family with the exception of one.	24657534	Heidenreich et al., 2013
TERT	−245 bp from the ATG start site in the TERT promoter	non-coding	Disrupts a preexisting non-canonical Ets2 binding site in the proximal region of the TERT promoter, adjacent to an E-box	Found in Bladder cancer, acts as a modifier of the effect of TERT promoter mutations on patient survival and disease recurrence	5:g.1295349A>G	5,1295349,1295349,A,G	ENST00000310581			5'Flank					FALSE		Bladder cancer patients with TERT promoter mutations in tumors showed almost two-fold decreased survival and increased disease recurrence in the absence but not in the presence of the variant allele for the rs2853669 polymorphism (PMID: 24101484)	24657534	Heidenreich et al., 2013